Esperion Therapeutis.Inc. sell platon
Start price
04.12.24
/
0%
€3.28
Target price
04.12.25
-
Performance (%)
3.35%
End price
07.12.24
€3.39
Summary
This prediction ended on 07.12.24 with a price of €3.39. With a performance of 3.35%, the SELL prediction by platon for Esperion Therapeutis.Inc. was trending in the wrong direction This prediction was marked as speculative and is excluded from platon's performance statistics.Esperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | -3.133% | -3.133% | 42.521% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by platon for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
Sell Esperion Therapeutis.Inc.
In the thread Trading Esperion Therapeutis.Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.